8-K: Hims & Hers Health Expands Board with Appointment of Anja Manuel

Hims & Hers Health has increased its board size to eleven and appointed Anja Manuel as a new independent director, effective immediately.

Summary

• Hims & Hers Health, Inc. has increased the size of its board of directors from ten to eleven members.
• Anja Manuel, age 49, has been appointed to fill the newly created board vacancy, effective April 24, 2024.
• Ms. Manuel will serve until the 2024 annual meeting of stockholders or until her successor is elected.
• The board has determined that Ms. Manuel meets the independence requirements of the New York Stock Exchange and the Securities Exchange Act of 1934.
• Ms. Manuel has not yet been appointed to any board committees.
• She will receive compensation as outlined in the company's proxy statement filed on April 26, 2024.
• Ms. Manuel will also enter into the company's standard indemnification agreement.
• There are no known arrangements or family relationships that influenced her appointment.
• Ms. Manuel is not involved in any current or proposed transactions with the company requiring disclosure.

Sentiment

Score: 7

Explanation: The document reflects a positive corporate governance move with the appointment of a new independent director, which is generally viewed favorably by investors.

Positives

• The appointment of Anja Manuel adds an independent voice to the board.
• The expansion of the board may bring diverse perspectives and expertise.
• Ms. Manuel's appointment is in line with the company's director compensation program.

Industry Context

Board appointments are a common practice for public companies to ensure proper governance and oversight. The appointment of an independent director like Anja Manuel is a positive step for Hims & Hers Health, aligning with best practices in corporate governance.

Comparison to Industry Standards

• The appointment of an independent director is a standard practice for companies listed on the New York Stock Exchange, similar to other publicly traded companies like Teladoc Health and GoodRx.
• The process of board expansion and appointment aligns with typical corporate governance procedures seen in the healthcare technology sector.
• The compensation structure for Ms. Manuel is expected to be consistent with industry norms for non-executive directors.

Management Changes

Stakeholder Impact

• Shareholders may view the appointment of an independent director positively, as it enhances corporate governance.
• The appointment does not have a direct impact on employees, customers, suppliers, or creditors.

Next Steps

• Ms. Manuel will serve on the board until the 2024 annual meeting of stockholders.
• The board may appoint Ms. Manuel to specific committees in the future.

Key Dates

Keywords

board of directors, corporate governance, independent director, Anja Manuel, Hims & Hers Health, board appointment